Cargando…

Pulmonary flow profile and distensibility following acute pulmonary embolism

OBJECTIVE: Proof of concept study evaluating CMR as screening tool for chronic thromboembolic pulmonary hypertension (CTEPH) in patients treated for acute pulmonary embolism (PE). MATERIALS AND METHODS: Right and left ventricular function of 15 consecutive patients treated for PE and 10 consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales: Klok, Frederikus A, Romeih, Soha, Westenberg, Jos JM, Kroft, Lucia JM, Huisman, Menno V, de Roos, Albert
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055838/
https://www.ncbi.nlm.nih.gov/pubmed/21332981
http://dx.doi.org/10.1186/1532-429X-13-14
_version_ 1782200147437944832
author Klok, Frederikus A
Romeih, Soha
Westenberg, Jos JM
Kroft, Lucia JM
Huisman, Menno V
de Roos, Albert
author_facet Klok, Frederikus A
Romeih, Soha
Westenberg, Jos JM
Kroft, Lucia JM
Huisman, Menno V
de Roos, Albert
author_sort Klok, Frederikus A
collection PubMed
description OBJECTIVE: Proof of concept study evaluating CMR as screening tool for chronic thromboembolic pulmonary hypertension (CTEPH) in patients treated for acute pulmonary embolism (PE). MATERIALS AND METHODS: Right and left ventricular function of 15 consecutive patients treated for PE and 10 consecutive patients in whom PE was excluded was estimated at baseline by cardiac CT and at 6 months follow-up by CMR. Additionally, during the follow-up visit, pulmonary artery (PA) hemodynamics were studied by CMR and the presence of pulmonary hypertension by echocardiography. RESULTS: CT measured right ventricular ejection fraction (RVEF) was lower in patients with PE compared to patients without PE at time of diagnosis (median 47%, interquartile range 39-53 vs. 55%, 52-58; p = 0.014). After 6 months follow up, the RVEF between patients treated for PE and patients without PE were not statistically significant different (55%, 52-60 versus 54%, 51-57; p = 0.57), as were distensibility index (0.18 ± 0.18 versus 0.25 ± 0.18, p = 0.20), mean velocity (14.1 ± 3.9 cm/s versus 14.0 ± 2.5 cm/s, p = 0.81), peak velocity (86.5 ± 22 cm/s versus 89.6 ± 13 cm/s, p = 0.43) and time to peak PA blood flow velocity (142 ± 49 ms versus 161 ± 29 ms, p = 0.14). One patient was diagnosed with CTEPH and CMR revealed poor right systolic function, decreased PA distensibility and flow velocity, and a systolic notch in the PA flow profile consistent with persistent PA obstruction. CONCLUSION: In this small series, right ventricular performance and PA flow profiles of patients treated for 6 months after PE are equivalent to those parameters in normal patients.
format Text
id pubmed-3055838
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30558382011-03-12 Pulmonary flow profile and distensibility following acute pulmonary embolism Klok, Frederikus A Romeih, Soha Westenberg, Jos JM Kroft, Lucia JM Huisman, Menno V de Roos, Albert J Cardiovasc Magn Reson Research OBJECTIVE: Proof of concept study evaluating CMR as screening tool for chronic thromboembolic pulmonary hypertension (CTEPH) in patients treated for acute pulmonary embolism (PE). MATERIALS AND METHODS: Right and left ventricular function of 15 consecutive patients treated for PE and 10 consecutive patients in whom PE was excluded was estimated at baseline by cardiac CT and at 6 months follow-up by CMR. Additionally, during the follow-up visit, pulmonary artery (PA) hemodynamics were studied by CMR and the presence of pulmonary hypertension by echocardiography. RESULTS: CT measured right ventricular ejection fraction (RVEF) was lower in patients with PE compared to patients without PE at time of diagnosis (median 47%, interquartile range 39-53 vs. 55%, 52-58; p = 0.014). After 6 months follow up, the RVEF between patients treated for PE and patients without PE were not statistically significant different (55%, 52-60 versus 54%, 51-57; p = 0.57), as were distensibility index (0.18 ± 0.18 versus 0.25 ± 0.18, p = 0.20), mean velocity (14.1 ± 3.9 cm/s versus 14.0 ± 2.5 cm/s, p = 0.81), peak velocity (86.5 ± 22 cm/s versus 89.6 ± 13 cm/s, p = 0.43) and time to peak PA blood flow velocity (142 ± 49 ms versus 161 ± 29 ms, p = 0.14). One patient was diagnosed with CTEPH and CMR revealed poor right systolic function, decreased PA distensibility and flow velocity, and a systolic notch in the PA flow profile consistent with persistent PA obstruction. CONCLUSION: In this small series, right ventricular performance and PA flow profiles of patients treated for 6 months after PE are equivalent to those parameters in normal patients. BioMed Central 2011-02-18 /pmc/articles/PMC3055838/ /pubmed/21332981 http://dx.doi.org/10.1186/1532-429X-13-14 Text en Copyright ©2011 Klok et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Klok, Frederikus A
Romeih, Soha
Westenberg, Jos JM
Kroft, Lucia JM
Huisman, Menno V
de Roos, Albert
Pulmonary flow profile and distensibility following acute pulmonary embolism
title Pulmonary flow profile and distensibility following acute pulmonary embolism
title_full Pulmonary flow profile and distensibility following acute pulmonary embolism
title_fullStr Pulmonary flow profile and distensibility following acute pulmonary embolism
title_full_unstemmed Pulmonary flow profile and distensibility following acute pulmonary embolism
title_short Pulmonary flow profile and distensibility following acute pulmonary embolism
title_sort pulmonary flow profile and distensibility following acute pulmonary embolism
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055838/
https://www.ncbi.nlm.nih.gov/pubmed/21332981
http://dx.doi.org/10.1186/1532-429X-13-14
work_keys_str_mv AT klokfrederikusa pulmonaryflowprofileanddistensibilityfollowingacutepulmonaryembolism
AT romeihsoha pulmonaryflowprofileanddistensibilityfollowingacutepulmonaryembolism
AT westenbergjosjm pulmonaryflowprofileanddistensibilityfollowingacutepulmonaryembolism
AT kroftluciajm pulmonaryflowprofileanddistensibilityfollowingacutepulmonaryembolism
AT huismanmennov pulmonaryflowprofileanddistensibilityfollowingacutepulmonaryembolism
AT deroosalbert pulmonaryflowprofileanddistensibilityfollowingacutepulmonaryembolism